Maxim Group analyst Michael Okunewitch has maintained their bullish stance on LCTX stock, giving a Buy rating on January 3.Stay Ahead of the ...

Roche's strategic acquisition of Poseida Pharmaceuticals positions them as a leader in the allogeneic cell therapy market.

For the first time, a patient with type 1 diabetes has undergone an islet transplantation using genetically modified ...

Political and economic uncertainty hangs over the industry, while major bets on metabolic and immune disease drug research are set to play out.

Phibro Animal Health is focusing on new developments along with incremental registrations and growing volumes of existing ...

Morgan Stanley likes financials, energy, real estate, and domestically-focused materials and consumer-goods companies.